Sandhya Srinivasan | Infochange News and Features | August 2015 In the last decade, there have been many reports of unethical and illegal clinical trials in India. It is only recently that the government framed rules to monitor their conduct.… Continue reading
Dr. Yashasvi Suvarna, Dr.Rathai Rajagopalan | World Journal of Pharmacy and Pharmaceutical Sciences | Vol 4 Issue 7 | 2015 Abstract India has been a hub for conducting various multi centre trials. The Central Drugs Standard Control Organisation (CDSCO), headed… Continue reading
Amar Jesani, S Srinivasan, Sarojini N, Vaibhao Ambhore, Veena Johari | Economic and Political Weekly | Vol 50, Issue 14 | 4 April 2015 This article provides a detailed critique of the formulae to provide compensation to subjects of clinical… Continue reading
Swadhin Mondal, Dinesh Abrol | Institute for Studies in Industrial Development | March 2015 Abstract This study shows that many global clinical trials organisations have relocated their clinical trial (CT) research units to India. The Indian CT industry has become… Continue reading
A. Nair | The Pharmaceutical Journal | 12 March 2015 An avalanche of reforms to rules governing the conduct of clinical trials in India has led to an exodus of drug companies and research organisations. Shirin Abdul Khan was 16… Continue reading
Ravindra B. Ghooi, Deepa Divekar | Perspectives in Clinical Research | 5(4) | 2014 | Source NCBI-PMC Abstract Aims and Objectives: Sponsors need to pay for management of all serious adverse events suffered by subjects in a clinical trial and to… Continue reading
